Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the DsDNA Anti Double Stranded DNA IgG Test By EIA is 7 days.

What are the prerequisites for the test DsDNA Anti Double Stranded DNA IgG Test By EIA

  • There are no specific prerequisites for the test DsDNA Anti Double Stranded DNA IgG Test By EIA.

What are the measure values for the test DsDNA Anti Double Stranded DNA IgG Test By EIA

Measurement Value
Normal Range Less than 30 IU/mL
Borderline Range 30-40 IU/mL
Positive Range Greater than 40 IU/mL

What does this test DsDNA Anti Double Stranded DNA IgG Test By EIA identify?

This test, DsDNA Anti Double Stranded DNA IgG Test By EIA, identifies the presence of anti-double stranded DNA (dsDNA) antibodies in the blood. These antibodies are typically found in individuals with autoimmune diseases such as systemic lupus erythematosus (SLE). The test helps in the diagnosis and monitoring of these conditions by detecting the antibodies that target the genetic material in the cell nucleus. Elevated levels of dsDNA antibodies can indicate active disease and may also be associated with more severe symptoms in patients with autoimmune disorders.

Why is this test DsDNA Anti Double Stranded DNA IgG Test By EIA taken?

Why is the DsDNA Anti Double Stranded DNA IgG Test By EIA taken?

The DsDNA Anti Double Stranded DNA IgG Test By EIA is taken to diagnose and monitor autoimmune diseases, particularly systemic lupus erythematosus (SLE). This test is specifically used to detect the presence of IgG antibodies against double-stranded DNA, which are commonly found in patients with SLE.

By measuring the levels of these antibodies, healthcare providers can assess disease activity, monitor treatment effectiveness, and make informed decisions about the management of the autoimmune disease. The test results can also help differentiate SLE from other autoimmune conditions and guide the selection of appropriate therapies.

No FAQs available.

Customer Google Rating